Mid-treatment PET predicts progression in hypofractionated accelerated radiation therapy for lung tumors

被引：0
|
作者：
Chang, Christine N. [1 ]
Fillion, Edith [2 ]
Chapman, Chris [1 ]
Rao, Aarti [1 ]
Wakelee, Heather [2 ]
Ganjoo, Kristen [2 ]
Le, Quynh-Thu [1 ]
Maxim, Peter [1 ]
Quon, Andrew [2 ]
Graves, Edward E. [2 ]
Loo, Billy W. [1 ]
机构：
[1] Stanford Univ Hosp, Stanford, CA 94305 USA
[2] Stanford Canc Ctr, Stanford, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S939 / S939
页数：1
相关论文
共 50 条
  • [1] Treatment of Ultracentral Lung Tumors with Hypofractionated Radiation Therapy
    Nsouli, T.
    Alden, R.
    Ennis, W.
    Mix, M.
    Bogart, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S617 - S617
  • [2] Mid-treatment FDG-PET predicts disease progression in patients with non-small cell lung cancer
    Olson, M. R.
    Weerasuriya, D. K.
    Wakelee, H. A.
    Quon, A.
    Maxim, P. G.
    Le, Q.
    Graves, E. E.
    Loo, B. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S504 - S504
  • [3] Preliminary Results of Accelerated Hypofractionated Radiation Therapy for Small Central Lung Tumors
    Hatayama, Y.
    Aoki, M.
    Kawaguchi, H.
    Hirose, K.
    Sato, M.
    Akimoto, H.
    Takai, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E462 - E462
  • [4] MID-TREATMENT TARC AND MID-TREATMENT FDG-PET PREDICT FOR PROGRESSION FREE SURVIVAL IN CLASSICAL HODGKIN LYMPHOMA
    Plattel, W. J.
    van den Berg, A.
    Visser, L.
    Glaudemans, A.
    Diepstra, A.
    van Imhoff, G.
    HAEMATOLOGICA, 2016, 101 : 31 - 31
  • [5] Accelerated Hypofractionated Magnetic Resonance Guided Adaptive Radiation Therapy for Ultracentral Lung Tumors
    La Rosa, Alonso
    Mittauer, Kathryn E.
    Bassiri, Nema
    Rzepczynski, Amy E.
    Chuong, Michael D.
    Yarlagadda, Sreenija
    Kutuk, Tugce
    Mcallister, Nicole C.
    Hall, Matthew D.
    Gutierrez, Alonso N.
    Tolakanahalli, Ranjini
    Mehta, Minesh P.
    Kotecha, Rupesh
    TOMOGRAPHY, 2024, 10 (01) : 169 - 180
  • [6] Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic Factors
    Harris, Jeremy P.
    Chang-Halpenny, Christine N.
    Maxim, Peter G.
    Quon, Andrew
    Graves, Edward E.
    Diehn, Maximilian
    Loo, Billy W., Jr.
    CLINICAL LUNG CANCER, 2015, 16 (06) : 475 - 485
  • [7] Accelerated Hypofractionated Radiation Therapy for the Central and Ultracentral Tumors of the Lung - Analysis of Doses to the Organs at Risk
    Karasawa, K.
    Kitou, S.
    Machitori, Y.
    Hayakawa, S.
    Ito, K.
    Ogawa, H.
    Shimizuguchi, T.
    Taguchi, K.
    Shibata, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E116 - E116
  • [8] Prognostic Metrics on Serial PET for Lung Tumors Treated With Hypofractionated Radiation
    Harris, J. P.
    Chang-Halpenny, C. N.
    Maxim, P. G.
    Quon, A.
    Graves, E. E.
    Diehn, M.
    Loo, B. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S511 - S511
  • [9] Accelerated Hypofractionated Radiation Therapy for Centrally Located Lung Tumors Not Suitable for Stereotactic Body Radiation Therapy (SBRT) or Concurrent Chemoradiotherapy (CRT)
    Zeng, K. L.
    Poon, I.
    Ung, Y. C.
    Zhang, L.
    Cheung, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E719 - E720
  • [10] Hypofractionated Stereotactic Radiation Therapy for Large and Central Lung Tumors
    Bongers, E.
    Dahele, M. R.
    Haitsbeek, C. J.
    de Haan, P. F.
    Verbakel, W. F.
    Slotman, B. J.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S549 - S550
12345